1. |
Wang ZH, Sun J, Liu Y, et al. Impact of atopy on the severity and extrapulmonary manifestations of childhood Mycoplasma pneumoniae pneumonia. J Clin Lab Anal, 2019, 33(5): e22887.
|
2. |
Vincent JL, Pereira AJ, Gleeson J, et al. Early management of sepsis. Clin Exp Emerg Med, 2014, 1(1): 3-7.
|
3. |
Mahendra M, Jayaraj BS, Limaye S, et al. Factors influencing severity of community-acquired pneumonia. Lung India, 2018, 35(4): 284-289.
|
4. |
Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int, 2006, 70(4): 771-780.
|
5. |
Christov M, Jüppner H. Phosphate homeostasis disorders. Best Pract Res Clin Endocrinol Metab, 2018, 32(5): 685-706.
|
6. |
Kuo G, Lee CC, Yang SY, et al. Hyperphosphatemia is associated with high mortality in severe burns. PLoS One, 2018, 13(1): e0190978.
|
7. |
Padelli M, Aubron C, Huet O, et al. Is hypophosphataemia an independent predictor of mortality in critically ill patients with bloodstream infection? A multicenter retrospective cohort study. Aust Crit Care, 2021, 34(1): 47-54.
|
8. |
Pistolesi V, Zeppilli L, Fiaccadori E, et al. Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies. J Nephrol, 2019, 32(6): 895-908.
|
9. |
García Martín A, Varsavsky M, Cortés Berdonces M, et al. Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia. Endocrinol Diabetes Nutr (Engl Ed), 2020, 67(3): 205-215.
|
10. |
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版). 中华结核和呼吸杂志, 2016, 39(4): 253-279.
|
11. |
Geerse DA, Bindels AJ, Kuiper MA, et al. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care, 2010, 14(4): R147.
|
12. |
Tranquada RE, Grant WJ, Peterson CR. Lactic acidosis. Arch Intern Med, 1966, 117(2): 192-202.
|
13. |
Sternbach GL, Varon J. Severe hyperphosphatemia associated with hemorrhagic shock. Am J Emerg Med, 1992, 10(4): 331-332.
|
14. |
Kebler R, McDonald FD, Cadnapaphornchai P. Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. Am J Med, 1985, 79(5): 571-576.
|
15. |
Miller CJ, Doepker BA, Springer AN, et al. Impact of serum phosphate in mechanically ventilated patients with severe sepsis and septic shock. J Intensive Care Med, 2020, 35(5): 485-493.
|
16. |
Wang HB, Zhang LD, Liao WH, et al. Hyperphosphatemia rather than hypophosphatemia indicates a poor prognosis in patients with sepsis. Clin Biochem, 2021, 91: 9-15.
|
17. |
Malinowska J, Małecka-Giełdowska M, Bańkowska D, et al. Hypermagnesemia and hyperphosphatemia are highly prevalent in patients with COVID-19 and increase the risk of death. Int J Infect Dis, 2022, 122: 543-549.
|
18. |
Lochy S, Jacobs R, Honoré PM, et al. Phosphate induced crystal acute kidney injury - an under-recognized cause of acute kidney injury potentially leading to chronic kidney disease: case report and review of the literature. Int J Nephrol Renovasc Dis, 2013, 6: 61-64.
|
19. |
Thongprayoon C, Cheungpasitporn W, Chewcharat A, et al. Admission serum phosphate levels and the risk of respiratory failure. Int J Clin Pract, 2020, 74(4): e13461.
|
20. |
Cheungpasitporn W, Thongprayoon C, Mao MA, et al. Admission serum phosphate levels predict hospital mortality. Hosp Pract (1995), 2018, 46(3): 121-127.
|
21. |
Cheungpasitporn W, Thongprayoon C, Hansrivijit P, et al. Impact of admission calcium-phosphate product on 1-year mortality among hospitalized patients. Adv Biomed Res, 2020, 9: 14.
|
22. |
Lau WL, Pai A, Moe SM, et al. Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis, 2011, 18(2): 105-112.
|
23. |
Wang S, Wu MY, Qin L, et al. DAXX mediates high phosphate-induced endothelial cell apoptosis in vitro through activating ERK signaling. PeerJ, 2020, 8: e9203.
|
24. |
Di Marco GS, Hausberg M, Hillebrand U, et al. Increased inorganic phosphate induces human endothelial cell apoptosis in vitro. Am J Physiol Renal Physiol, 2008, 294(6): F1381-F1387.
|
25. |
Liu YL, Lin KH, Tamilselvi S, et al. Elevated phosphate levels trigger autophagy-mediated cellular apoptosis in H9c2 cardiomyoblasts. Cardiorenal Med, 2017, 8(1): 31-40.
|
26. |
Bech A, Blans M, Raaijmakers M, et al. Hypophosphatemia on the intensive care unit: individualized phosphate replacement based on serum levels and distribution volume. J Crit Care, 2013, 28(5): 838-843.
|
27. |
李世刚, 陈喆, 颜卫峰. 重症肺炎患者血磷与淋巴细胞亚群及预后的相关性分析. 标记免疫分析与临床, 2021, 28(2): 197-202.
|
28. |
鲍强, 周明根, 廖文华, 等. 低磷血症对机械通气患者脱机的影响. 中华危重病急救医学, 2021, 33(7): 821-825.
|
29. |
Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 2003, 58(5): 377-382.
|
30. |
España PP, Capelastegui A, Quintana JM, et al. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia. Eur Respir J, 2003, 21(4): 695-701.
|
31. |
Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax, 2009, 64 Suppl 3: iii1-iii55.
|
32. |
España PP, Capelastegui A, Gorordo I, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med, 2006, 174(11): 1249-1256.
|
33. |
Charles PG, Davis JS, Grayson ML. Rocket Science and the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) guidelines for severe community-acquired pneumonia. Clin Infect Dis, 2009, 48(12): 1796.
|